LONDON--(BUSINESS WIRE)--The report, breast biopsy devices market 2019-2023, has been added to Technavio's catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product, modality, end-user and geography for the forecast period 2019-2023.
To learn more about the global trends impacting the future of market research: Download Free Sample Report
The report on the breast biopsy devices market 2019-2023 includes:
Breast biopsy devices market analysis and forecast 2018-2023: Features
- Competitive landscape
-
Market segmentation
- Learning method
- Course type
- Market drivers
- Market trends
- Market challenges
- Five forces analysis
- Market landscape
- Market sizing & forecast
Breast Biopsy Devices Market 2018-2023: Competitive Landscape
- Vendors covered
-
Vendor classification
- Argon Medical Devices Inc.
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- Planmed Oy
- Scion Medical Technologies LLC
- Siemens Healthineers AG
Breast Biopsy Devices Market Landscape 2019-2023: End-user
- Hospitals - Market size and forecast 2018-2023
- ASCs - Market size and forecast 2018-2023
- Breast cancer specialty centers and clinics - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
Breast Biopsy Devices Market Landscape 2019-2023: Product
- Biopsy needles and systems - Market size and forecast 2018-2023
- Biopsy image-guided systems - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
Breast Biopsy Devices Market Landscape 2019-2023: Modality
- Stereotactic X-ray guided breast biopsy - Market size and forecast 2018-2023
- Ultrasound-guided breast biopsy - Market size and forecast 2018-2023
- MRI-guided breast biopsy - Market size and forecast 2018-2023
Register for a free trial today and gain instant access to 10,000+ market research reports.
Technavio's SUBSCRIPTION platform
Growing prevalence of breast cancer cases will drive the breast biopsy devices market
Breast cancer is one of the commonest forms of cancer, which is majorly observed in the female population worldwide. The geriatric female population is more likely to develop breast cancer. However, even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. Thus, such factors are thereby expected to drive the growth of the breast biopsy devices market.
Paradigm shift toward adoption of breast biopsy robot systems – An emerging trend in the breast biopsy devices market
The growing adoption of minimally invasive procedures for breast cancer screening has increased the demand for technologically advanced breast biopsy devices. The demand for accurate and efficient surgical procedures has increased the demand for robotic platforms, surgical navigation systems, and artificial intelligence. The incorporation of robotics can reduce surgical and other complications associated with these procedures. These devices will also help in performing breast biopsies more precisely and thereby, improving the surgical outcomes during the breast biopsy process.
Other Key Topics Covered in the Report are:
MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
Get Full Report: https://www.technavio.com/report/breast-biopsy-devices-market-industry-analysis
CUSTOMER LANDSCAPE
DECISION FRAMEWORK
DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
MARKET TRENDS
- Business strategies
- Programs to detect breast cancer at the early stages
- Paradigm shift toward adoption of breast biopsy robot systems
Technavio also offers Custom Research services providing focused, comprehensive, and tailored research.
For More Information Click Here
Browse Related Health Care Reports:
- Global Breast Cancer Therapeutics Market 2019-2023: The Global Breast Cancer Therapeutics Market 2019-2023 is forecasted to grow at a CAGR close to 8% during the period 2019-2023. The breast cancer therapeutics market size will increase by USD 8.09 billion during the forecast period of 2019-2023.
- Global Digital Breast Tomosynthesis Market 2019-2023: The Digital Breast Tomosynthesis Market is forecasted to grow at a CAGR of 13% during the period 2019-2023. The digital breast tomosynthesis market size will increase by USD 718 million during the forecast period of 2019-2023.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
